206 related articles for article (PubMed ID: 25492964)
41. Downregulation of neuregulin 1-ErbB4 signaling and antidepressant properties of ketamine: ErbB4 expressing pyramidal neurons may play a role.
Bernstein HG; Keilhoff G; Steiner J; Laube G; Bogerts B
J Mol Neurosci; 2015 Feb; 55(2):372-3. PubMed ID: 24874581
[TBL] [Abstract][Full Text] [Related]
42. Constitutive loss and acute pharmacological manipulation of ErbB4 signaling do not affect attention and inhibitory control in mice.
Marchisella E; Wijnands R; Koopmans B; Spijker S; Loos M
Genes Brain Behav; 2018 Jan; 17(1):56-69. PubMed ID: 28792672
[TBL] [Abstract][Full Text] [Related]
43. The S100A4 Protein Signals through the ErbB4 Receptor to Promote Neuronal Survival.
Pankratova S; Klingelhofer J; Dmytriyeva O; Owczarek S; Renziehausen A; Syed N; Porter AE; Dexter DT; Kiryushko D
Theranostics; 2018; 8(14):3977-3990. PubMed ID: 30083275
[TBL] [Abstract][Full Text] [Related]
44. Exploration of a new drug that targets YAP.
Fujii M
J Biochem; 2012 Sep; 152(3):209-11. PubMed ID: 22761457
[TBL] [Abstract][Full Text] [Related]
45. The Hippo Signaling Pathway in Development and Disease.
Zheng Y; Pan D
Dev Cell; 2019 Aug; 50(3):264-282. PubMed ID: 31386861
[TBL] [Abstract][Full Text] [Related]
46. Cell density regulates cancer metastasis via the Hippo pathway.
Sharif GM; Wellstein A
Future Oncol; 2015; 11(24):3253-60. PubMed ID: 26561730
[TBL] [Abstract][Full Text] [Related]
47. Hyaluronan Degradation Promotes Cancer via Hippo-YAP Signaling: An Intervention Point for Cancer Therapy.
Ooki T; Hatakeyama M
Bioessays; 2020 Jul; 42(7):e2000005. PubMed ID: 32449813
[TBL] [Abstract][Full Text] [Related]
48. The roles of YAP T425A mutation in the regulation of YAP activity.
Yang YL; Zou ZZ; Fang Y; Mao B
Yi Chuan; 2017 Jul; 39(7):675-682. PubMed ID: 28757481
[TBL] [Abstract][Full Text] [Related]
49. The Hippo Show Must Go On: YAP Activation as a Therapeutic Strategy in Colorectal Cancer.
Veschi V; Stassi G
Cell Stem Cell; 2020 Oct; 27(4):501-502. PubMed ID: 33007230
[TBL] [Abstract][Full Text] [Related]
50. A protein tertiary structure mimetic modulator of the Hippo signalling pathway.
Adihou H; Gopalakrishnan R; Förster T; Guéret SM; Gasper R; Geschwindner S; Carrillo García C; Karatas H; Pobbati AV; Vazquez-Chantada M; Davey P; Wassvik CM; Pang JKS; Soh BS; Hong W; Chiarparin E; Schade D; Plowright AT; Valeur E; Lemurell M; Grossmann TN; Waldmann H
Nat Commun; 2020 Oct; 11(1):5425. PubMed ID: 33110077
[TBL] [Abstract][Full Text] [Related]
51. Immunofluorescence Study of Endogenous YAP in Mammalian Cells.
Rausch V; Hansen CG
Methods Mol Biol; 2019; 1893():97-106. PubMed ID: 30565128
[TBL] [Abstract][Full Text] [Related]
52. Dysregulation of the Hippo pathway signaling in aging and cancer.
Yeung YT; Guerrero-Castilla A; Cano M; Muñoz MF; Ayala A; Argüelles S
Pharmacol Res; 2019 May; 143():151-165. PubMed ID: 30910741
[TBL] [Abstract][Full Text] [Related]
53. Olfactomedin-like protein OLFML1 inhibits Hippo signaling and mineralization in osteoblasts.
Murakami K; Kikugawa S; Kobayashi Y; Uehara S; Suzuki T; Kato H; Udagawa N; Nakamura Y
Biochem Biophys Res Commun; 2018 Oct; 505(2):419-425. PubMed ID: 30266405
[TBL] [Abstract][Full Text] [Related]
54. Evasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds.
Amin ARMR; Karpowicz PA; Carey TE; Arbiser J; Nahta R; Chen ZG; Dong JT; Kucuk O; Khan GN; Huang GS; Mi S; Lee HY; Reichrath J; Honoki K; Georgakilas AG; Amedei A; Amin A; Helferich B; Boosani CS; Ciriolo MR; Chen S; Mohammed SI; Azmi AS; Keith WN; Bhakta D; Halicka D; Niccolai E; Fujii H; Aquilano K; Ashraf SS; Nowsheen S; Yang X; Bilsland A; Shin DM
Semin Cancer Biol; 2015 Dec; 35 Suppl():S55-S77. PubMed ID: 25749195
[TBL] [Abstract][Full Text] [Related]
55. Discovering the Hippo pathway protein-protein interactome.
Moya IM; Halder G
Cell Res; 2014 Feb; 24(2):137-8. PubMed ID: 24418760
[TBL] [Abstract][Full Text] [Related]
56. Targeting the Hippo signalling pathway for cancer treatment.
Nakatani K; Maehama T; Nishio M; Goto H; Kato W; Omori H; Miyachi Y; Togashi H; Shimono Y; Suzuki A
J Biochem; 2017 Mar; 161(3):237-244. PubMed ID: 28003431
[TBL] [Abstract][Full Text] [Related]
57. Tumor Suppression by p53: Bring in the Hippo!
Aylon Y; Oren M
Cancer Cell; 2017 Oct; 32(4):397-399. PubMed ID: 29017051
[TBL] [Abstract][Full Text] [Related]
58. Studying YAP-Mediated 3D Morphogenesis Using Fish Embryos and Human Spheroids.
Asaoka Y; Morita H; Furumoto H; Heisenberg CP; Furutani-Seiki M
Methods Mol Biol; 2019; 1893():167-181. PubMed ID: 30565134
[TBL] [Abstract][Full Text] [Related]
59. Stem cells go soft: pliant substrate surfaces enhance motor neuron differentiation.
Wang N
Cell Stem Cell; 2014 Jun; 14(6):701-3. PubMed ID: 24905160
[TBL] [Abstract][Full Text] [Related]
60. Building bridges to the cortex.
Hanashima C; Molnár Z; Fishell G
Cell; 2006 Apr; 125(1):24-7. PubMed ID: 16615886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
